Emergency Departments Archives

AstraZeneca’s Covid-19 vaccine candidate begins late-stage U.S. study

"Operation Warp Speed" Initiative, Brazil, Britain, Clinical Trials, Coronavirus Infections, Covid-19 Data, COVID-19 Vaccines, Elections, Emergency Departments, Japan, National Institutes of Health, Novel Coronavirus, Oxford University, Placebo, R&D, Russia, South Africa, Studies

AstraZeneca Plc has begun enrolling adults for a U.S.-funded, 30,000-subject late-stage study of the company’s high-profile Covid-19 vaccine candidate.

August 31, 2020/by Andrew Humphreys

Webinar: Meeting the Needs of Complex Patient Populations Through Care Collaboration

Emergency Departments, Medicaid, Patients, Webinars

Dr. Brian Patel, Chief of Emergency Medicine at Sturdy Memorial Hospital, and Deborah Jean Parsons, Ph.D. Director of Integrated Care at Aspire Health Alliance, share actionable best practices for developing better community partnerships to support patients struggling with complex comorbid physical, behavioral, mental, and SDOH challenges.

April 1, 2020/by Administrator

Webinar: Meeting the Needs of Complex Patient Populations Through Care Collaboration

Emergency Departments, Health, Patients, Webinars

Caring for patients with complex physical, behavioral, and mental health conditions requires a community effort—especially when those patients also face social determinants of health. Learn how communities are working together to achieve over 100% growth in patient engagement and a 78% reduction in ED utilization through care collaboration.

March 24, 2020/by Administrator

First Antibiotic With New Mechanism of Action Approved in Almost 20 Years

Antibiotics, Approvals, Community-Acquired Bacterial Pneumonia (CABP), Emergency Departments, Emergency Rooms, European Medicines Agency (EMA), Fast Track Designation, FDA, FDA/Regulatory, Priority Review, U.S. Centers for Disease Control and Prevention, Wholesale Acquisition Cost

The U.S. FDA gave Nabriva Therapeutics a thumbs-up for the company’s oral and intravenous formulations of Xenleta (lefamulin) to treat community-acquired bacterial pneumonia in adults.

August 20, 2019/by BioSpace